Filter
1419
Filtered Results: 1419
Text search:
World
Health
Organization,
Pan
American
Health
Organization
Featured
Recommendations
155
New Publications
270
Language
Document type
No document type
558
Studies & Reports
313
Guidelines
277
Manuals
99
Strategic & Response Plan
59
Fact sheets
36
Training Material
32
Situation Updates
17
Resource Platforms
11
Infographics
9
Brochures
5
Online Courses
3
Countries / Regions
Latin America and the Carribbean
159
Global
88
Brazil
69
Colombia
35
Venezuela
29
Haiti
25
Paraguay
24
Africa
23
Mozambique
20
India
17
Angola
17
Argentina
15
North America
12
Guinea-Bissau
10
Peru
10
Western and Central Europe
10
Syria
9
Kenya
9
Nigeria
8
Ecuador
8
Myanmar / Burma
8
Chile
8
Middle East and North Africa
8
Ethiopia
7
Philippines
7
Nepal
7
Asia
7
Russia
7
Liberia
6
Ukraine
6
Bolivia
6
Yemen
6
West and Central Africa
6
Ghana
5
Uganda
5
South Sudan
5
South Africa
5
Eastern Europe
5
Zambia
4
Tanzania
4
Cambodia
4
Indonesia
4
Bangladesh
4
Eswatini/ Swaziland
4
Mexico
4
East and Southern Africa
4
Burkina Faso
3
Sierra Leone
3
Congo, Democratic Republic of
3
Pakistan
3
Malawi
3
Honduras
3
Guatemala
3
Iran
3
Zimbabwe
2
China
2
Rwanda
2
Papua New Guinea
2
Sudan
2
El Salvador
2
South–East Asia Region
2
Western Pacific Region
2
Moldova
2
Uruguay
2
Jamaica
2
Spain
2
Guinea
1
Mali
1
Morocco
1
Saudi Arabia
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Thailand
1
Benin
1
Central African Republic
1
Dominican Republic
1
Namibia
1
Cuba
1
Botswana
1
Greece
1
Libya
1
Madagascar
1
Lesotho
1
Nicaragua
1
Eastern Europe and Central Asia
1
Fiji
1
Italy
1
Albania
1
Laos
1
Tajikistan
1
Estonia
1
Kyrgyzstan
1
Georgia
1
Vietnam
1
Japan
1
France
1
Tunisia
1
Portugal
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
387
Clinical Guidelines
166
Public Health
107
Women & Child Health
78
Key Resources
76
Capacity Building
23
Pharmacy & Technologies
23
Annual Report MEDBOX
1
Toolboxes
COVID-19
252
Mental Health
130
HIV
91
Rapid Response
79
TB
75
NTDs
69
Planetary Health
65
Zika
61
Caregiver
42
NCDs
41
AMR
33
Disability
31
Global Health Education
30
Natural Hazards
23
Pharmacy
21
Conflict
20
Ebola
19
Cholera
16
Health Financing Toolbox
15
Refugee
13
Specific Hazards
6
Polio
5
Typhoon
2
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance includes a step-by-step process to be followed after the...
В настоящем документе подчеркиваются основные аспекты организации безопасного управления медицинскими отходами для того, чтобы лица, вырабатывающие
политику, п...
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used i...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage exist...
On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and in consultation with the International Severe Acute Respiratory and Emerging Infection Consortium(ISARIC), Global Research Collaboration for Infectious Dis...
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the op...
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators ...
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other <... workers can contribute to improving hypertension detection and management.
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A...
The COVID-19 pandemic arrived in an evolving epidemiological context where some countries are experiencing a progressive decrease in HIV positivity in their testing programme as they are moving closer to the first 95 target. Distinguishing changes in HIV testing services due to the COVID-19 pandemic...
This report presents country, regional and global estimates of low birth weight for 2000, together with a detailed description of the methods used in calculating the estimates. Some limited data on trends are also included. The limitations of low-birth-weight data are described and recommendations a...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Guidance module.
The QualityRights training and orientation modules have been developed to enhance the knowledge, skills and understanding of key stakeholders on how to promote the rights of people with psychosocial, intellectual or cognitive disabilities, improve the quality of services and suppo...
Obesity and diet-related noncommunicable diseases (NCDs) have been steadily increasing globally, and with them, a pressing need to implement effective responses to address the contributing factors. Among the available evidence-based policy options that enable healthier choices and improved diets is ...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
